Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia

Jing Chen, Cynthia A. Pise-Masison, Joanna H. Shih, John C. Morris, John E. Janik, Kevin C. Conlon, Anne Keating, Thomas A. Waldmann

Blood (2013) 121 (11): 2029–2037.

https://doi.org/10.1182/blood-2012-05-427773

Published: 2013

Includes: Supplemental data

Journal Articles

Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia

Thomas A. Waldmann, Kevin C. Conlon, Donn M. Stewart, TatYana A. Worthy, John E. Janik, Thomas A. Fleisher, Paul S. Albert, William D. Figg, Shawn D. Spencer, Mark Raffeld, Jean R. Decker, Carolyn K. Goldman, Bonita R. Bryant, Michael N. Petrus, Stephen P. Creekmore, John C. Morris

Blood (2013) 121 (3): 476–484.

https://doi.org/10.1182/blood-2012-08-450585

Published: 2013

Includes: Supplemental data

Journal Articles

Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma

Charles B. Simone, II, John C. Morris, Donn M. Stewart, Nicole E. Urquhart, John E. Janik, Robert J. Kreitman, Elena Lita, Kevin Conlon, Gilian Wharfe, Thomas A. Waldmann, Aradhana Kaushal

Blood (2012) 120 (9): 1816–1819.

https://doi.org/10.1182/blood-2012-01-401349

Published: 2012

Journal Articles

Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia

Jing Chen, Mike Petrus, Richard Bamford, Joanna H. Shih, John C. Morris, John E. Janik, Thomas A. Waldmann

Blood (2012) 119 (1): 137–143.

https://doi.org/10.1182/blood-2011-04-346759

Published: 2012

Includes: Supplemental data

Journal Articles

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP

Wei Ju, Meili Zhang, Jian-kang Jiang, Craig J. Thomas, Unsong Oh, Bonita R. Bryant, Jing Chen, Noriko Sato, Yutaka Tagaya, John C. Morris, John E. Janik, Steven Jacobson, Thomas A. Waldmann

Blood (2011) 117 (6): 1938–1946.

https://doi.org/10.1182/blood-2010-09-305425

Published: 2011

Includes: Supplemental data

Journal Articles

Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia

Jing Chen, Mike Petrus, Bonita R. Bryant, Vinh Phuc Nguyen, Carolyn K. Goldman, Richard Bamford, John C. Morris, John E. Janik, Thomas A. Waldmann

Blood (2010) 116 (26): 5948–5956.

https://doi.org/10.1182/blood-2010-04-277418

Published: 2010

Journal Articles

A Phase I Clinical Trial of Treatment of B-Cell Malignancies with Autologous Anti-CD19-CAR-Transduced T Cells

James N. Kochenderfer, Mark E. Dudley, Maryalice Stetler-Stevenson, Wyndham H. Wilson, John E. Janik, Debbie-Ann N. Nathan, Irina Maric, Mark Raffeld, Steven A. Feldman, Richard A. Morgan, Steven A. Rosenberg

Blood (2010) 116 (21): 2865.

https://doi.org/10.1182/blood.V116.21.2865.2865

Published: 2010

Journal Articles

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Kieron Dunleavy, MD, Pratip Chattopadhyay, PhD, Junichi Kawada, Sara Calattini, Emma Gostick, PhD, David Price, MD, PhD, Mario Roderer, PhD, Jeffrey Cohen, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, John E Janik, MD, Elaine S Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 963.

https://doi.org/10.1182/blood.V116.21.963.963

Published: 2010

Journal Articles

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler-Stevenson, Steven A. Feldman, Irina Maric, Mark Raffeld, Debbie-Ann N. Nathan, Brock J. Lanier, Richard A. Morgan, Steven A. Rosenberg

Blood (2010) 116 (20): 4099–4102.

https://doi.org/10.1182/blood-2010-04-281931

Published: 2010

Includes: Supplemental data

Journal Articles

The Role of JAK3 mutations in Adult T-Cell Leukemia/Lymphoma.

Natalina E Elliott, Susan Cleveland, Victor Grann, John E. Janik, Utpal P. Dave, MD

Blood (2009) 114 (22): 1940.

https://doi.org/10.1182/blood.V114.22.1940.1940

Published: 2009

Journal Articles

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Kieron Dunleavy, MD, Stefania Pittaluga, MD, Kevin Tay, MD, Nicole Grant, MPH, Clara C Chen, MD, Margaret Shovlin, RN, Seth Steinberg, PhD, Louis M Staudt, MD, PhD, Elaine S Jaffe, MD, John E Janik, MD, Wyndham H Wilson, MD, PhD

Blood (2009) 114 (22): 106.

https://doi.org/10.1182/blood.V114.22.106.106

Published: 2009

Journal Articles

Population Pharmacokinetics of Siplizumab (MEDI-507), a Humanized Anti-CD2 Monoclonal Antibody, in Cancer Patients.

Chunlin Chen, MD, PhD, John E Janik, MD, Karen Kaucic, MD, Lorin Roskos, PhD, Bahija Jallal, PhD, Gabriel J. Robbie, PhD

Blood (2009) 114 (22): 2670.

https://doi.org/10.1182/blood.V114.22.2670.2670

Published: 2009

Journal Articles

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, Wyndham H. Wilson

Blood (2009) 113 (24): 6069–6076.

https://doi.org/10.1182/blood-2009-01-199679

Published: 2009

Journal Articles

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

Cynthia A. Pise-Masison, Michael Radonovich, Kathleen Dohoney, John C. Morris, Deirdre O'Mahony, Min-Jung Lee, Jane Trepel, Thomas A. Waldmann, John E. Janik, John N. Brady

Blood (2009) 113 (17): 4016–4026.

https://doi.org/10.1182/blood-2008-08-175901

Published: 2009

Includes: Supplemental data

Journal Articles

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Kamal Sharma, DO, John E. Janik, MD, Deirdre O’Mahony, MD, Donn Stewart, MD, Stefania Pittaluga, MD, Maryalice Stetler-Stevenson, MD, PhD, Elaine S. Jaffe, MD, Mark Raffeld, MD, Thomas A. Fleisher, MD, Cathryn C. Lee, NP, Nicole Urquhart, MD, Seth Steinberg, PhD, Thomas A. Waldmann, MD, John C. Morris, MD

Blood (2008) 112 (11): 2010.

https://doi.org/10.1182/blood.V112.11.2010.2010

Published: 2008

Journal Articles

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

Kieron Dunleavy, MD, Stefania Pittaluga, MD, PhD, Nicole Grant, MPH, Seth Steinberg, PhD, Margaret Shovlin, RN, Kevin Tay, MD, John E. Janik, MD, Elaine S. Jaffe, M.D., Wyndham H. Wilson, MD, PhD

Blood (2008) 112 (11): 3590.

https://doi.org/10.1182/blood.V112.11.3590.3590

Published: 2008

Journal Articles

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

Kieron Dunleavy, MD, Richard Little, MD, Alan S. Wayne, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, PhD, Elaine S. Jaffe, MD, Seth Steinberg, PhD, Robert Yarchoan, MD, PhD, Jorge A. Carrasquillo, MD, John E. Janik, MD, Wyndham H. Wilson, MD, PhD

Blood (2008) 112 (11): 3606.

https://doi.org/10.1182/blood.V112.11.3606.3606

Published: 2008

Journal Articles

Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma

Deirdre O’Mahony, MD, John E Janik, MD, Jorge A. Carrasquillo, MD, Pamela Seam, MD, Joseph A Fiorillo, MD, Donn Stewart, MD, Chang H Paik, PhD, Suzanne Fioravanti, RN, Millie Whatley, RNMT, Stefania Pittaluga, MD, PhD, Martin W Brechbiel, PhD, John C Morris, MD, Thomas A Waldmann, MD

Blood (2008) 112 (11): 231.

https://doi.org/10.1182/blood.V112.11.231.231

Published: 2008

Journal Articles

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism

Jing Chen, Mike Petrus, Bonita R. Bryant, Vinh Phuc Nguyen, Mindy Stamer, Carolyn K. Goldman, Richard Bamford, John C. Morris, John E. Janik, Thomas A. Waldmann

Blood (2008) 111 (10): 5163–5172.

https://doi.org/10.1182/blood-2007-09-113654

Published: 2008

Journal Articles

EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies.

Deirdre O’Mahony, MD, John C. Morris, MD, Maryalice Stetler-Stevenson, MD, Helen Matthews, RN, Stefania Pittaluga, MD, Paul Albert, PhD, Karen Kaucic, MD, Luz Hammershaimb, MD, Thomas A. Waldmann, MD, John E. Janik, MD

Blood (2007) 110 (11): 3565.

https://doi.org/10.1182/blood.V110.11.3565.3565

Published: 2007

NARROW

Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia

Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia

Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma

Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP

Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia

A Phase I Clinical Trial of Treatment of B-Cell Malignancies with Autologous Anti-CD19-CAR-Transduced T Cells

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

The Role of JAK3 mutations in Adult T-Cell Leukemia/Lymphoma.

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Population Pharmacokinetics of Siplizumab (MEDI-507), a Humanized Anti-CD2 Monoclonal Antibody, in Cancer Patients.

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism

EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only